Company Filing History:
Years Active: 2019-2025
Title: The Innovative Contributions of Dal-Hee Min
Introduction
Dal-Hee Min is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of gene introduction and cell fate modulation. With a total of five patents to his name, Min's work has the potential to advance scientific research and therapeutic applications.
Latest Patents
Dal-Hee Min's latest patents include a method for confirming the introduction of foreign genes into cells and a method for manufacturing the introduction of foreign genes into cells. The first patent describes a technique that allows for easy identification of foreign gene introduction by detecting fluorescent emissions. This method reduces the influence of additional elements, as it does not require any reporter gene or selectable marker. Furthermore, it eliminates the need for an additional sampling process, enabling a more accurate and straightforward screening process. The second patent involves a composition comprising porous silica particles that carry a cell fate modulating factor. This innovative composition allows for the treatment of various cells, delivering the modulating factor to a stable target receptor while minimizing toxicity to the subject cells. The sustained release of at least 99 wt. % of the cell fate modulating factor enables control over the fate of the subject cells.
Career Highlights
Throughout his career, Dal-Hee Min has worked with notable organizations, including Lemonex Inc. and Seoul National University. His experience in these institutions has contributed to his expertise in biotechnology and innovation.
Collaborations
Dal-Hee Min has collaborated with several professionals in his field, including Cheolhee Won and Jieon Lee. These collaborations have likely enhanced his research and development efforts.
Conclusion
Dal-Hee Min's innovative work in gene introduction and cell fate modulation showcases his significant contributions to biotechnology. His patents reflect a commitment to advancing scientific knowledge and improving therapeutic techniques.